The Latest Breaking News from Vaccine

New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox.

Graham was a healthy 34-year-old until he developed COVID in July 2020. Along with his wife and children, he had a fever, a cough, breathlessness, profound fatigue and he lost his sense of smell.

Dame Sarah Gilbert and Dr Catherine Green helped create the Oxford, AstraZeneca vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours.

Poor messaging around booster shots has left millions at risk, researchers say

With cases of monkeypox inexplicably on the rise outside of Africa - where the viral disease is endemic - public health officials are using contact tracing, isolation and targeted vaccination to curb its spread.

Some countries do not allow entry without proof of full vaccination, while others operate strict testing regimes

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…

Health authorities in France and Denmark want to start a vaccination campaign targeting adults who have been exposed to monkeypox – a milder version of smallpox that spreads easily through sexual activity.

There has been an outbreak of monkeypox cases in a number of countries that are not endemic for the virus. Monkeypox is caused by an orthopoxvirus that is closely related to the virus that caused smallpox. Monkeypox is an animal virus that occasionally infects humans after they are bitten or…

Pfizer says it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries